TAYSHA GENE THERAPIES INC (TSHA) Institutional Ownership and Insiders Activity
TAYSHA GENE THERAPIES INC (TSHA) is widely held by institutional investors, with 205 firms reporting positions valued at approximately $2.03B based on SEC Form 13F filings for the quarter ended June 30, 2026.
Avoro Capital Advisors Llc is the largest disclosed holder, reporting approximately $162.68M in TSHA holdings in its latest filing.
Institutional Holders
205
Total Reported Value
$2.03B
Largest Holder
Avoro Capital Advisors Llc
Largest Position
$162.68M
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
43
Funds Exiting Positions
28
Top Institutional Owners
View allInvestorReported Balance
- Avoro Capital Advisors Llc$162.68M
- Ra Capital Management, L.P.$160.41M
- Goldman Sachs Group Inc$154.68M
- Blackrock, Inc.$140.91M
- Vestal Point Capital, Lp$132.22M
TSHA News
All news- Heights Capital Management Inc Q2 2026 Portfolio Activity Analysis
Aug 18, 2026 · valut.ai
Related TSHA Institutional Insights:
- TSHA 13F Institutional Holders
- TSHA Superinvestors
- TSHA Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- TSHA Insider Trading & SEC Form 4 Activity
- TSHA Articles
- Top Institutional Investor Stock Rankings